ClinicalTrials.gg
Drug

Bupivacaine clinical trials

Also written Marcaine, Exparel, SKY0402 and Marcain.

Includes 298 studies of Liposomal Bupivacaine.

studies test it
1,198
open now
169
in phase 3
160
first study started
2002
Related medicines add 5 studies

Counted the way a researcher would: Bupivacaine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Bupivacaine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bupivacaine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Oct 1972 · MARCAINE HYDROCHLORIDE PRESERVATIVE FREE · NDA 016964 (FDA, Drugs@FDA)
European Union
24 Sept 2020 · Zynrelef · EMEA/H/C/005205 (EMA; in a combination; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bupivacaine
360
Bupivacaine Hydrochloride
51
Bupivacain
48
Bupivacaine 0.25%
22
Bupivacaine Injection
20

Brand

Marcaine
154
Exparel
28
Sensorcaine
19
XaraColl
3

Development codes

SKY0402
13
BPV10NO
1
BPV11NO
1

Other names

Marcain
10

In one entry with another drug

Given together, or one or the other

HTX-011
17
Bupivacaine-epinephrine
11
Dexmedetomidine & Bupivacaine.
8
Bupivacaine-fentanyl
7
Bupivacaine + Fentanyl
5
Bupivacaine + Dexamethasone
4
Bupivacaine with Dexamethasone
4
Bupivacaine, fentanyl
4

Studies by the year they started

1,192 studies that test it; most in 2024 (98); 2 more planned to start later

Studies that test Bupivacaine, by start year
YearStudies
20021
20032
20043
20058
20068
200714
200818
200923
201020
201124
201233
201345
201463
201581
201679
201788
201888
201995
202052
202181
202264
202375
202498
202570
202659

By phase

A phase 1/2 study counts in both.

Early Phase 1
30
Phase 1
59
Phase 2
151
Phase 3
160
Phase 4
466
No phase
380

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 91 · Other 1,107

Pacira Pharmaceuticals, Inc (53) · Assiut University (38) · Ain Shams University (28) · Cairo University (26) · Mayo Clinic (22) · Ataturk University (22) · Heron Therapeutics (18) · Istanbul University (17)

Often tested with

Tested in the same studies.

Dexamethasone (47) · Dexmedetomidine (43) · Lidocaine (38) · Ropivacaine (38) · Fentanyl (37) · Epinephrine (29) · Morphine (27) · Meloxicam (18)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Bupivacaine is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 65, 9 in phase 3

Studies that test Bupivacaine, phase 3 first.

Studies

Open first, then newest update. How each study uses Bupivacaine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 1,198

See all 1,198 studies that test Bupivacaine →

Given beside what is tested · 266 — Bupivacaine is usual care or a partner of the new treatment

Showing 20 of 266.

As the comparator · 89 — what is tested is compared with Bupivacaine

Showing 20 of 89.

What changed recently

From the registry's own updates since Oct 16, 2026.

Codes

What other systems call Bupivacaine · ClinicalTrials.gg INT007098

  • MeSH (NLM) D002045BupivacaineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Y8335394ROBUPIVACAINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1815Confirmed FDA, Wikidata
  • Wikidata Q422806bupivacaine-(RS)Confirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62011BupivacaineOne source FDA
  • DrugBank DB00297One source Wikidata

Also registered as bupivacaine hydrochloride (UNII 7TQO7W3VT8 · RxNorm 267396) and bupivacaine hydrochloride anhydrous (UNII AKA908P8J1 · RxNorm 1375412).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.